Categories: News

NYSE Content Advisory: Pre-Market Update + S&P 500 closes above 6,600 for first time

NEW YORK, Sept. 16, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on September 16th

- Advertisement -
  • Stocks are mixed Tuesday morning after the S&P 500 closed above 6,600 for the first time ever. The major averages received a boost after President Trump spoke favorably about trade talks with China in Madrid.
  • The two-day FOMC meeting kicks off today, with the Fed likely to cut interest rates for the first time this year on Wednesday. Over 95% of traders anticipate a 25-basis point cut.
  • Last night, the Senate confirmed Stephen Miran to serve on the Fed’s Board of Governors. President Trump’s pick to replace Adrianna Kugler, Miran will be one of 12 officials voting on interest rate decisions once he is sworn in.

Opening Bell
Ralph Lauren (NYSE: RL) celebrates its 2025 Investor Day

- Advertisement -

Closing Bell
Western Alliance Bank (NYSE: WAL) celebrates its 20th anniversary of listing

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2774302/NYSE_Market_Update_Sept_16.mp4
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–sp-500-closes-above-6-600-for-first-time-302557671.html

- Advertisement -

Recent Posts

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE…

2 hours ago

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE…

2 hours ago

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am…

2 hours ago

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus As Nature Intended, Ingredients

NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS, AND MENTAL CLARITY…

11 hours ago

Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness

New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED AS A NEW…

11 hours ago

Sugar Clean Drops: Top Blood Sugar Support Supplement for Metabolic Wellness and Energy Support

SUGAR CLEAN DROPS ANNOUNCED AS A NEW SUPPLEMENT SUPPORTING HEALTHY BLOOD SUGAR AND METABOLIC WELLNESS…

11 hours ago